Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites

Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews he...

Full description

Saved in:
Bibliographic Details
Main Author: Lois A. Lampson (auth)
Format: Electronic Book Chapter
Language:English
Published: Frontiers Media SA 2018
Series:Frontiers Research Topics
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_49994
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2018 xx |||||o ||| 0|eng d
020 |a 978-2-88945-535-5 
020 |a 9782889455355 
040 |a oapen  |c oapen 
024 7 |a 10.3389/978-2-88945-535-5  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Lois A. Lampson  |4 auth 
245 1 0 |a Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites 
260 |b Frontiers Media SA  |c 2018 
300 |a 1 electronic resource (95 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews herein emphasize the brain's place among other tumor sites. Two major topics are addressed. THE SITE: WHAT CAN WE EXPECT FROM IMMUNOTHERAPY WHEN THE TARGET IS IN THE BRAIN? Experience with immunotherapy for different targets in the brain, including tumor and also pathogens, is reviewed. Long-standing assumptions are confronted. The potential for beneficial responses is stressed. BRAIN TUMOR IMMUNOTHERAPY: WHAT HAVE WE LEARNED SO FAR? Clinical experience with brain tumor immunotherapy, from a variety of centers, is reviewed. Primary tumors, emphasizing glioblastoma, and brain metastases are each considered. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a blood-brain barrier 
653 |a tumor antigen 
653 |a brain immunology 
653 |a glioblastoma 
653 |a brain tumor immunotherapy 
653 |a brain metastases 
653 |a brain tumor 
653 |a immune privilege 
856 4 0 |a www.oapen.org  |u https://www.frontiersin.org/research-topics/2186/immunotherapy-for-tumor-in-the-brain-insights-from---and-for---other-tumor-sites  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/49994  |7 0  |z DOAB: description of the publication